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Abstract
Background: Fibroblast growth factors (FGF) are essential key players during embryonic development. Through their
specific cognate receptors (FGFR) they activate intracellular cascades, finely regulated by modulators such as Sprouty.
Several FGF ligands (FGF1, 2, 7, 9, 10 and 18) signaling through the four known FGFRs, have been implicated in lung
morphogenesis. Although much is known about mammalian lung, so far, the avian model has not been explored for lung
studies.
Methodology/Principal Findings: In this study we provide the first description of fgf10, fgfr1-4 and spry2 expression
patterns in early stages of chick lung development by in situ hybridization and observe that they are expressed similarly to
their mammalian counterparts. Furthermore, aiming to determine a role for FGF signaling in chick lung development, in
vitro FGFR inhibition studies were performed. Lung explants treated with an FGF receptor antagonist (SU5402) presented an
impairment of secondary branch formation after 48 h of culture; moreover, abnormal lung growth with a cystic appearance
of secondary bronchi and reduction of the mesenchymal tissue was observed. Branching and morphometric analysis of lung
explants confirmed that FGFR inhibition impaired branching morphogenesis and induced a significant reduction of the
mesenchyme.
Conclusions/Significance: This work demonstrates that FGFRs are essential for the epithelial-mesenchymal interactions that
determine epithelial branching and mesenchymal growth and validate the avian embryo as a good model for pulmonary
studies, namely to explore the FGF pathway as a therapeutic target.
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Introduction
Fibroblast growth factors (FGF) are secreted proteins that play
an important role in multiple biological processes, such as
proliferation, survival, migration and differentiation, as well as in
the morphogenesis of branching organs such as the lung, kidney
and pancreas, among others [1,2]. FGF signaling depends on the
activation of specific cell surface receptors (FGFR) encoded by four
distinct genes, fgfr1-4. Due to alternative splicing, these can
produce numerous FGFR isoforms that differ in their binding
affinity towards the FGF ligands. FGFRs are single-pass
transmembrane proteins with tyrosine kinase activity (RTK)
which, upon ligand binding to the extracellular domain of the
receptor, initiate a signal transduction cascade (Ras-MAP kinase,
PI3 kinase/Akt) that ultimately results in gene expression
modification [3,4]. fgf and fgfr expression depend on cell type
and physiological conditions and are strictly regulated in both time
and space. In fact, when mutated or misexpressed, the modified
genes can cause developmental disorders and can also lead to
cancer [5,6]. The FGF-FGFR interaction requires the intervention
of heparin or heparin sulfate proteoglycans in order to stabilize the
formation of a receptor dimer bound to the FGF molecules. The
FGF-FGFR pathway is precisely controlled by modulators of
RTK signaling, including members of the Sprouty (Spry) family of
proteins that inhibit FGF-induced MAPK activation to varying
degrees. Moreover, Spry modulation of RTK signaling is very
flexible and highly cell- and context-dependent, and its expression
is induced by the growth factor cascades that it regulates [7].
In the embryonic lung, FGF signaling is an essential component
of the regulatory networks operating between epithelium and
mesenchyme at several stages of development and its perturbation
results in dramatic abnormalities of epithelial branching and
differentiation. Only a restricted number of FGF ligands are
present in the embryonic lung (FGF1, 2, 7, 9, 10 and 18; reviewed
in [8]), and only FGF10 has been shown to be absolutely essential
for lung formation, as fgf10 knockout mice fail to develop lungs,
leading to neonatal death [9]. During morphogenesis, fgf10 is
dynamically expressed in the lung mesenchyme surrounding the
distal buds, and acts as a chemoattractant of lung epithelium
controlling induction and directional outgrowth through its
specific cell surface receptor (FGFR2b) [10,11]. Targeted deletion
of FGFR2b also prevents branching, causing the trachea to
terminate as a blind sac [12]. The same occurs in fgf10 knockouts,
meaning that the fully functional pathway is necessary for lung
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formation. Furthermore, FGF signaling in the lung is regulated by
Spry2, a RTK modulator that inhibits lung growth and
morphogenesis [13]. Abrogation of spry2 expression stimulates
lung branching morphogenesis and increases epithelial prolifera-
tion [14]. Conversely, spry2 overexpression results in reduced
branching and decreased epithelial cell proliferation [13].
In the chicken embryo, Gallus gallus variant domesticus, lung buds
become evident on day 3.5 of embryogenesis, appearing as paired
protuberances on the lateroventral aspect of the foregut of the
developing embryo [15]. Endodermal bud formation and septation
of the respiratory tract and esophagus is defined by Tbx4 expression,
which is present in the visceral mesoderm of the lung primordium,
by activation of mesodermal Fgf10 expression. This signaling system
is of great importance in the events that lead to primary bud
formation [16]. Later, the single bud divides into left and right
primordial lungs that progressively elongate caudally while separat-
ing and shifting towards the coelomic cavity [15]. As development
proceeds, branching morphogenesis occurs along with the formation
of the air sacs, in the ventral region. The developing respiratory tract
presents region-specific mesenchymal expression of the Hoxb genes,
Bmp-2, Bmp-4, Wnt-5a, and Wnt-11 [17], that govern differences
between dorsal and ventral compartments of the lung. Furthermore,
variations in the rate of diffusion of FGF10 between ventral and
dorsal regions, due to differential levels of heparin sulfate
proteoglycans and a special mesenchymal structure, seem to account
for ventral cyst formation and dorsal branching morphogenesis [18].
In this report, we have examined transcript location of fgf10, fgfr1,
fgfr2, fgfr3, fgfr4 and spry2 by in situ hybridization at early stages of chick
lung development. FGFR in vitro inhibition studies were also performed
and branching and morphometric analysis were carried out in order to
assess the role of FGF signaling pathway in chick lung development.
Results
Expression pattern of fgf10 during chick lung
development
In order to analyze the expression of some members of the FGF
signaling pathway in early stages of chick lung development, whole
mount in situ hybridization (ISH) experiments were performed, after
which representative examples of hybridized lungs from different
stages of development were sectioned for histology. Embryos with 4
to 6 days of incubation were collected and lungs were carefully
dissected and staged according to the number of secondary bronchi
formed: b1 stage corresponds to lungs with only one secondary
bronchus, at b2 stage the lung presents two secondary bronchi and
at b3 stage it presents three secondary bronchi.
We found that fgf10 is expressed in the distal pulmonary
mesenchyme surrounding the tip of the main bronchus (Figure 1A
and D, arrows), and also in the dorsal mesenchyme adjacent to the
emerging secondary buds, in the three stages studied (Figure 1,
dark arrowheads). No epithelial expression is observed (Figure 1,
open arrowhead and asterisks).
Expression patterns of fgfr1, fgfr2, fgfr3 and fgfr4 during
chick lung development
fgfr1 is expressed throughout all pulmonary epithelium and
mesenchyme of the chick respiratory tract, in all stages studied
Figure 1. fgf10 expression pattern in early stages of chick lung development. Representative examples of whole mount in situ hybridization
(A–C) and sections of hybridized lungs (D–F). fgf10 is expressed in the mesenchyme surrounding the emerging new buds (dark arrowheads) and in
the distal mesenchyme surrounding the main bronchus (arrow); no epithelial expression is observed in either the main bronchus (open arrowhead) or
in secondary buds (asterisks). Magnification: A - 6.36; B/C - 56; D/F - 106.
doi:10.1371/journal.pone.0017660.g001
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(Figure 2). Histological sectioning of hybridized lungs confirmed
this ubiquitous expression: fgfr1 transcript is present in the
pulmonary epithelium of the main bronchus (Figure 2D–F, open
arrowhead) and of emerging secondary branches (Figure 2E and F,
asterisks); moreover, it is observed over all mesenchymal
compartments, mainly in the posterior ventral region (Figure 2F,
dark arrowhead).
fgfr2 is clearly expressed in the lung epithelium, mainly in distal-
most region of the main bronchi (Figure 3, arrows) and in the
secondary lung buds (Figure 3, asterisks). Furthermore, it is also
present in distal peri-epithelial mesenchyme of the main bronchi
(Figure 3, dark arrowheads). No differences were observed in fgfr2
expression patterns in the three stages studied. In lung sections, it
is possible to observe that fgfr2 is less expressed in the most
proximal epithelium (Figure 3E and F, open arrowheads) when
compared with secondary bronchi epithelium (Figure 3E and F,
asterisks) and distal epithelium of the main bronchus (Figure 3D,
arrow). Moreover, it is expressed in the surrounding peri-epithelial
mesenchyme of both main and secondary bronchi (Figure 3D and
F, dark arrowheads).
fgfr3 mRNA is detected in the peri-epithelial mesenchyme of the
main bronchial tree, mostly in the proximal region adjacent to the
emerging secondary bronchi (Figure 4, dark arrowheads). fgfr3
transcript is absent from the pulmonary epithelium (Figure 4,
arrows and asterisks), and also from the distal mesenchyme
(Figure 4B). As the number of secondary bronchi increases,
mesenchymal peri-epithelial fgfr3 expression becomes progressively
more distal (Figure 4, open arrowheads). Histological sectioning of
hybridized lungs confirmed that fgfr3 is not expressed in lung
epithelium (Figure 4, arrows and asterisks) and is only expressed in
the mesenchyme (Figure 4, dark and open arrowheads).
fgfr4 appears to be expressed at a much lower level in the chick
respiratory tract in the stages studied. A very weak expression in
the epithelium of the secondary buds in b3 stage (Figure 5C,
asterisk) seems to come out, after a long developing period.
Mesenchyme seems clean even after a long period of incubation
with developing solution. Sectioning was not performed because
the low levels of expression would be undetectable.
Expression pattern of spry2 during chick lung
development
spry2 mRNA is present in the distal epithelium of the main
bronchi (Figure 6, arrows), in the epithelium of the emerging
secondary buds (Figure 6, asterisks) and also in the distal peri-
epithelial mesenchyme (Figure 6B and 6E, dark arrowhead). This
expression pattern is constant for the three stages studied. In lung
sections it is possible to observe that spry2 is expressed not only in
the distal-most epithelial cells (Figure 6D, open arrowhead), but
also in the adjacent layer of mesenchyme that borders growing
lung epithelium. Finally, the epithelial cells attached to the main
bronchus do not express spry2 (Figure 6F, dashed arrow).
Inhibition of FGF signaling results in abnormal lung
branching
In order to assess the role of FGF signaling pathway in early
stages of chick lung development, in vitro inhibition studies were
performed. Chick lungs from b1 to b3 stages were processed for
Figure 2. fgfr1 expression pattern in early stages of chick lung development. Representative examples of whole mount in situ hybridization
(A–C) and sections of hybridized lungs (D–F). fgfr1 presents a ubiquitous expression pattern observed in the pulmonary epithelium of the main
bronchus (open arrowheads) and in secondary buds (asterisks); and in distal ventral mesenchyme (dark arrowheads). Magnification: A/C - 56; D/E -
106; F - 46.
doi:10.1371/journal.pone.0017660.g002
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explant culture and incubated with two different doses of a FGF
receptor antagonist (SU5402), which is known to inhibit tyrosine
kinase activity of all four FGFRs by interacting with the catalytic
domain and thus blocking FGF signaling [19]. When compared
with DMSO controls (Figure 7A–C), SU5402 treated lungs do not
form new secondary branches after 48 h of incubation (Figure 7D–
I). Moreover, in SU5402 treated explants, secondary branches
present a cystic shape and the pulmonary mesenchyme is thinner
when compared with DMSO treated explants. Cell death was
assessed in these experimental conditions by TUNEL assay (Figure
S1). We found that apoptosis was absent from untreated, DMSO
and 20 mM treated explants and in 40 mM treated explants, only
minor cellular apoptosis levels were detected in the most distal part
of the lung. Hence, the described phenotypes are not due to
increased cell death in lung explants.
To confirm FGF signaling inhibition, treated explants were
hybridized with spry2 probe, a direct readout of FGF signaling
activity in the lung. As expected, SU5402 treated explants lack spry2
expression, meaning that FGF inhibition was successful in the doses
tested (Figure 7F and I), whereas in DMSO treated explants spry2 is
present (Figure 7C). The branching analysis of the fetal lung
explants is summarized in Figure 8. Both doses of FGFR inhibitor
induced a statistically significant difference (p,0.05) in the ratio of
total number of peripheral airway buds (D2/D0) when compared to
both untreated and DMSO treated explants, in the three stages
studied. Moreover, no statistical differences were found between
groups treated with 20 and 40 mM of SU5402 for all stages studied.
Morphometric analysis was performed by assessing total, epithelial
and mesenchymal lung explant area (Figure 9). Both doses of FGFR
inhibitor induced a statistically significant reduction (p,0.05) in
total and mesenchymal area ratio (D2/D0) when compared to both
untreated and DMSO treated explants, in the three stages studied;
in these conditions, no statistical differences were found between
groups treated with 20 or 40 mM of SU5402 in all stages studied.
On the other hand, regarding epithelial area ratio, only the higher
dose of inhibitor induced a statistically significant decrease (p,0.05)
when compared to both untreated and DMSO treated explants, in
the three stages studied.
Discussion
FGF signaling pathway is crucial for proper embryonic develop-
ment and it is known to play an important role in several stages of
lung morphogenesis (reviewed in [8]). Lung development is directed
by intrinsic epithelial-mesenchymal interactions that regulate cell
proliferation, fate, migration and differentiation, leading to branching
morphogenesis and ultimately to proper lung formation. These
signaling events are coordinated by bone morphogenetic proteins
(BMP), fibroblast growth factors (FGF), sonic hedgehog (SHH) and
Wnt signaling pathways, insoluble extracellular matrix proteins and
their receptors, as well as various transcription factors [1]. In this
study we analyze for the first time, the expression pattern of some
members of the FGF signaling pathway in early stages of chick lung
development, such as fgf10, fgfr1-4 and spry2. Moreover, FGF
inhibition studies were also performed in order to assess FGF
functional role in branching morphogenesis.
Although the anatomy of the avian lung differs from that of the
mammalian lung, both develop similarly and have anatomical
functional equivalents. Mammalian lung is asymmetrical and
branching occurs by reiterative dichotomous splitting of the airway
Figure 3. fgfr2 expression pattern in early stages of chick lung development. Representative examples of whole mount in situ hybridization
(A–C) and sections of hybridized lungs (D–F). fgfr2 is present in distal epithelium of main bronchus (arrow) and secondary bronchi (asterisks); peri-
epithelial mesenchyme of the main bronchus (dark arrowheads); open arrowheads, proximal epithelium. Magnification: A/C - 56; D, F - 206; E - 106.
doi:10.1371/journal.pone.0017660.g003
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epithelium into surrounding mesenchyme, generating a tree-like
structure that will give rise to the airways and alveoli [20]. On the
other hand, chick lung is symmetrical and two developmental
processes take place so the lung forms properly: secondary bronchi
sprout along the length of the primary bronchus and then tertiary
bronchi anastomose and interconnect with the secondary bronchi.
Ventrally, avian lung branches end in air sacs [21]. In both cases,
however, the airways develop by a succession of outgrowths and
extensions into the surrounding mesenchyme, which could be
governed by similar molecular mechanisms.
Expression pattern of FGF signaling members
We found that fgf10 is expressed in the distal mesenchyme of the
main bronchus and in the dorsal mesenchyme that surrounds the
Figure 4. fgfr3 expression pattern in early stages of chick lung development. Representative examples of whole mount in situ hybridization
(A–C) and sections of hybridized lungs (D–F). fgfr3 is absent from pulmonary epithelium (arrow, main bronchus; asterisks, secondary buds) and distal
mesenchyme but expression is observed in the peri-epithelial mesenchyme (dark arrowheads, open arrowheads). Magnification: A/C - 56; D/F - 106.
doi:10.1371/journal.pone.0017660.g004
Figure 5. fgfr4 expression pattern in early stages of chick lung development. Representative examples of whole mount in situ hybridization
(A–C). fgfr4 is not expressed in b1 and b2 stages. A weak expression is observed in secondary lung buds (asterisk) of b3 stage (C). Magnification: A/C -
56.
doi:10.1371/journal.pone.0017660.g005
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emerging secondary buds (Figure 1). This expression pattern is
consistent with what has been previously described in the mouse
model: fgf10 is expressed in the distal mesenchyme at sites where
prospective epithelial buds will appear governing the directional
outgrowth of lung buds during branching morphogenesis [10].
These data suggest that fgf10 may also be important for chick
airway development, functioning as a proliferative factor that
stimulates distal epithelial growth.
fgfr1 shows an ubiquitous expression in the epithelial and
mesenchymal compartments that is consistent with that described
for rat lung development (Figure 2) [22,23]. This expression
pattern suggests that FGFR1 could be responsible for capturing
proliferative factors, such as FGF9 that acts as a trophic factor for
distal mesenchyme, and FGF10 which is important for epithelial
proliferation, although through different isoforms, FGFR1c and
1b respectively [1].
fgfr2 is expressed throughout the epithelial compartment,
particularly in the most distal region of the main bronchus and
also in the growing secondary branches (Figure 3). This expression
pattern matches the one described for the mouse lung [10] and
suggests that, also in the chick model, FGFR2 might be activated
by FGF10 during the embryonic phase of development [11].
FGFR2 also binds to other ligands (FGF1, FGF3, FGF7), which
are primarily expressed in mesenchymal cells. Some mesenchymal
expression is also observed in the most distal peri-epithelial region
that might be activated by FGF1 [24], probably through the
FGFR2c isoform [25].
fgfr3 is present in the peri-epithelial mesenchyme of the
bronchial airway, mainly anteriorly to the emerging secondary
buds (Figure 4). Considering the fact that in later stages its
expression is progressively more distal, this might mean that it is
responsible for the uptake of differentiating growth factors with an
inhibitory growth action. This inhibitory function has already been
described in mouse chondrocyte proliferation and differentiation
[26].
Regarding fgfr4 expression, only a very faint expression was
observed in the secondary buds in the later stages (Figure 5). These
results are in accordance with the fact that this receptor binds to
several FGFs which have not been implicated in lung develop-
ment. Moreover, the presence of fgfr4 could only be detected in
pre-natal and early post-natal rat lungs [23]. It is also known that
fgfr3/fgfr4 knockout present late defects in pulmonary development
while single fgfr3 and fgfr4 knockouts do not show any lung
phenotype [27]. Considering the results obtained and the fact that
in the adult lung fgfr4 expression is absent, maybe this receptor has
a role only in the late stages. A summary diagram of the four FGF
receptor expression patterns is represented in Figure 10.
spry2 is localized to the distal tips of the main bronchus and
secondary branches (Figure 6). This expression pattern is in
accordance with what has been described in the literature for
rodent models where spry2 is expressed in the distal tip, as the bud
elongates toward a mesenchymal source of FGF10 [28]. Therefore
it seems that, also in the chick lung, spry2 is expressed in intimate
association with a FGF10 signaling center. In addition to the distal
epithelial expression, similar to what occurs in rodent models, spry2
is also significantly expressed in mesenchyme that surrounds
growing epithelial branches. The preservation of a distal
expression pattern, however, sustains the hypothesis that the
Figure 6. spry2 expression pattern in early stages of chick lung development. Representative examples of whole mount in situ hybridization
(A–C) and sections of hybridized lungs (D–F). spry2 is present in the pulmonary epithelium (arrow, distal main bronchus; asterisks, secondary buds)
and in the distal peri-epithelial mesenchyme (dark arrowheads). Open arrowheads and dashed arrow, epithelial cells. Magnification: A/C - 56; D, F -
206; E - 106.
doi:10.1371/journal.pone.0017660.g006
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FGF10-Spry2 system is also regulating lung branching morpho-
genesis in the chick lung.
FGF signaling inhibition
In vitro inhibition of FGF signaling by SU5402, a known
inhibitor of all FGF receptors, induced an abnormal lung growth
with a cystic appearance of secondary bronchi and a disruption of
the mesenchymal tissue (Figure 7). As stated previously, FGF
signaling plays an important role in lung branching morphogenesis
but so far these effects have not been described in the chick
embryonic lung. To demonstrate that this morphological alter-
ation was due to FGFR inhibition, lung explants were probed for
spry2 expression. As expected, SU5402 treated explants lack spry2
mRNA, supporting that FGF signaling is down-regulated, while in
DMSO treated explants (Figure 7C) and lung explants with no
supplementation (data not shown), spry2 is normally expressed.
Also, explants treated with SU5402 exhibit a dysplastic structure
without an increase in the number of secondary bronchi after 48 h
of culture (expressed as D2/D0 ratio, Figure 8). However, we
cannot rule out the possibility that other signaling pathways may
be inhibited in these culture conditions, also contributing for the
observed explant morphology. Vascular endothelial growth factor
receptor (VEGFR) is known to be required for pulmonary vascular
development and epithelial branching [29] and is inhibited by
SU5402 [30]. Also, when this signaling pathway is blocked in fetal
rat lung explants by a specific VEGFR inhibitor, a slight increase
Figure 7. In vitro FGF inhibition studies in chick lung explants. Representative examples of stage b2 lung explant culture (A–B; D–E; G–H) and
ISH for spry2 (C, F, I). D0: 0 h, D2: 48 h of incubation. A–B, DMSO treated explants. D–E and G–H, SU5402 treated explants with 20 and 40 mM,
respectively. All images at the same magnification: 56.
doi:10.1371/journal.pone.0017660.g007
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in distal air space size is observed [31], although not to the extent
observed in the case of chick lung explants (our results).
Morphometric analysis of lung explants (Figure 9) clearly shows
that both doses of FGFR inhibitor induced a significant reduction
of the mesenchymal area, in the three stages studied. On the other
hand, the epithelial compartment seems to be less susceptible to
SU5402 inhibition since only the higher dose induced a statistical
difference. Considering the role of FGFs as proliferation factors, it
seems as if the mesenchyme is more sensitive to these extracellular
proteins than the epithelium.
Regarding the cystic shape of lung buds, theoretically there are
two possible explanations for this phenotype. It has been suggested
that either an increase in FGF diffusion rate or a saturating
amount of FGF signal should result in cyst formation [32]. In fact,
transiently induced FGF overexpression during fetal rat lung
development leads to the formation of cystic lung lesions [33]. On
the other hand, increased FGF diffusion accounts for the
formation of air sacs in the ventral chick lung [18]. Apparently,
none of these two situations match the experimental conditions
described in this work, however, an increase in FGF diffusion due
to the disrupted mesenchyme structure could contribute to the
cystic phenotype observed.
In conclusion, our work demonstrates the importance of FGFRs
in the epithelial-mesenchymal interactions that determine epithe-
lial branching and mesenchyme growth and consolidate our
understanding of the role of FGF signaling pathway in early chick
lung development.
Materials and Methods
Eggs and embryos
Fertilized chick (Gallus gallus) eggs, obtained from commercial
sources, were incubated for 4–6 days in a 49% humidified
atmosphere at 37uC. Embryonic chick lungs were carefully
dissected under a dissection microscope (Olympus SZX16, Japan)
and were then classified as stage b1, b2 or b3, taking into account
the number of secondary buds formed: 1, 2 or 3, respectively.
In situ hybridization
Lungs were fixed overnight at 4uC in a solution of 4%
formaldehyde with 2 mM EGTA in PBS at pH 7.5, rinsed in PBT
(PBS, 0.1% Tween 20), dehydrated in methanol and stored at
220uC. Whole mount in situ hybridization was performed as
previously described by Henrique et al. [34]. Lungs were then
photographed in PBT/0.1% azide with an Olympus U-
LH100HG camera coupled to Olympus SZX16 stereo micro-
scope. Hybridized chick lungs were fixed in paraformaldehyde
4%, embedded in 2-hydroxyethyl methacrylate (Heraeus Kulzer,
Germany) and processed for sectioning at 25 mm using a rotary
microtome (Leica RM 2155, Germany). Lung sections were
Figure 8. Branching analysis of stage b1, b2 and b3 lung explants treated with DMSO (n=10), SU5402 (20 mM and 40 mM) (n=10),
or grown without supplementation (untreated, n=10). Results are expressed as D2/D0 ratio. Data is represented as mean 6 SD. p,0.05: * vs
Untreated, ¥ vs DMSO.
doi:10.1371/journal.pone.0017660.g008
Figure 9. Morphometric analysis of stage b1, b2 and b3 lung explants treated with DMSO (n=10), SU5402 (20 mM and 40 mM)
(n=10), or grown without supplementation (untreated, n=10). Results are expressed as D2/D0 ratio. Data is represented as mean 6 SD.
p,0.05: * vs Untreated, ¥ vs DMSO, 1 vs 20 mM of SU5402.
doi:10.1371/journal.pone.0017660.g009
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photographed with an Olympus DP70 camera coupled to an
Olympus BX61 microscope.
Non isoform-specific FgfR1-4 probes were kindly provided by Dr.
Guojun Sheng [35]. Fgf10 probe was kindly provided by Dr. Ana
Certal (IGC, Portugal) and Spry2 probe by Dr. Delphine Duprez
[36]. Digoxigenin (DIG)-labeled probes were synthesized using
linearized plasmids and DIG RNA Labeling Mix (Roche Applied
Sciences, Germany) according to the manufacturer’s instructions.
Lung Explant Culture
After dissection in DPBS (Lonza, Switzerland), lungs were
transferred to Nucleopore polycarbonate membranes with an
8 mm pore size (Whatman, USA) and incubated in a 24-well
culture plates (Orange Scientific, Belgium). The membranes were
presoaked in 400 mL of Medium 199 (Sigma, USA) for 1 h before
the explants were placed on them. Floating cultures of the explants
were incubated in 200 mL Medium 199 supplemented with 5% heat
inactivated fetal calf serum (Invitrogen, USA), 10% chicken serum
(Invitrogen), 1% L-glutamine (Invitrogen), 1% penicillin 5000 IU/
mL, streptomycin 5000 IU/mL (Invitrogen) and 0.25 mg/mL
ascorbic acid (Sigma). Chick lung explants were incubated in a
5% CO2 incubator at 37uC for 48 h and the medium replaced at
24 h. The branching morphogenesis was monitored daily by
photographing the explants. At day 0 (D0: 0 h) and day 2 (D2: 48 h)
of culture, the total number of peripheral airway buds (branching)
was determined. For the morphometric analysis, the total and
epithelial areas were assessed at D0 and D2 using AxionVision Rel.
4.3 (Carl Zeiss GmbH, Germany). Epithelial area was defined by
the internal perimeter of the lung and total cross-sectional area was
defined by the outer perimeter; mesenchymal area was calculated as
the difference between total and epithelial area. Branching and
morphometric results were expressed as D2/D0 ratio. All
quantitative data are presented as mean 6 SD. Statistical analysis
was performed, using SigmaStat 3.5 (Systat Software Inc., USA), by
one-way ANOVA On Ranks and the Dunn test (branching) and
Turkey test (morphometric) were carried out for post-test analysis.
Statistical significance was set at p,0.05.
In order to inhibit the FGF signaling pathway, lung explants
(stages b1 to b3) were cultured with SU5402 (Calbiochem, UK),
an FGF receptor antagonist; SU5402 dissolved in DMSO was
added to the medium to achieve a final concentration of 20 and
40 mM (n = 10, per stage) and 0.1% DMSO. Control explants
consisted of medium containing DMSO at a final concentration of
1 mL/mL (n = 10, per stage). After culture, lung explants were
fixed overnight at 4uC and processed for ISH.
Supporting Information
Figure S1 TUNEL assay in chick lung explants. Apoptosis
was analyzed using the Cell Death Detection Kit (Roche Applied
Sciences) in all experimental groups. Briefly, explants were fixed
overnight in 4% paraformaldehyde (PFA) in PBS, permeabilized
with PBS/0.5% Triton X-100/0.1% sodium citrate for 4 h at room
temperature, and washed in PBS. Positive control explants were
incubated with DNase at 37uC for 1 h. Explants were incubated for
4 h, at 37uC with the TUNEL solution mix and washed at least
three times in PBS before visualization. Representative examples of
positive control (A), DMSO (B), 20 and 40 mM SU5402 (C and D,
respectively) treated stage b3 explants. Apoptosis is absent from
untreated (data not shown), DMSO and 20 mM SU5402 treated
explants (B and C, respectively). In 40 mM treated explants (D) only
minor cellular apoptosis levels were detected in the most distal part
of the lung. White arrows point to specific TUNEL staining.
(TIF)
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